aeaolxt bpc 157 BPC-157 — Evolved Science

The peptide's demonstrated safety in gastric juice stability and lack of toxic effects across wide dose ranges support its potential for gastrointestinal therapeutic applications pending further clinical validation

But itll still release it

Resuming protocols if symptoms return remains an option

WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use